After weighing both arguments, the recommendation lands on Underweight. The bull's strongest cards are tactical, not structural: Polymarket 92% floor at $365 is real-money positioning data hard to dismiss for a 1-week horizon; technical recovery from deeply oversold (RSI 25→56, MACD bullish cross, ATR compressing 38%) is genuine; $43.5B cash position genuinely limits catastrophic downside; Q3 delivery "beat" vs. consensus is a real near-term positive. For a 1-2 week tactical trade, the bull has a real edge. However, the bear wins the structural debate decisively: 175x forward P/E requiring Optimus + Robotaxi + FSD to inflect exactly on schedule with no execution slippage; structural margin compression (revenue +25.6% YoY but net income -5%; operating margin at 1.41% and falling under BYD pricing pressure); the 200 SMA declining overhead at $391 with Bollinger upper band confluence at $387; and 4%+ real rates for 12+ months compressing the NPV of long-dated optionality. The bear is also correct that Polymarket data is far weaker than the bull claims: 70% probability of NOT reaching $420 and 6% tail at $300 describe a range-bound stock with downside risk. The bull's bear-flag rebuttal is the decisive technical point: 90% deceleration in MACD histogram momentum in 14 sessions (6.64 → 0.70), RSI rolling over from 60.6 to 55.8 at resistance, and declining 200 SMA at $391 are textbook relief-rally-into-resistance signatures. ATR compression within a confirmed downtrend more often resolves to the downside. The $391 target is essentially a moving finish line that declines $3-4/week. The Q3 delivery "beat" trap is also significant: 486K vs. 497K year-ago is a -2.2% YoY decline; production (464K) trailing deliveries (486K) by 22K is channel inventory drawdown, not demand strength. Why not Sell: Polymarket 92% $365 floor and $43.5B cash position genuinely limit near-term downside; full Sell conviction would require break below $348 or clear Q3 earnings disappointment. Why not Hold: risk/reward over 3-6 months is genuinely asymmetric; with 175x forward P/E, 1.4% operating margin, declining 200 SMA overhead, and 4% real rates compressing optionality NPV, stock needs to be right about everything to hold $375; probability-weighted return is modestly negative.

POSITION SIZING: Reduce TSLA exposure to 50-70% of benchmark weight. If currently at benchmark weight, trim 30-50% of the position. If already underweight, maintain.

EXECUTION LEVELS: Trim zone: Sell into strength at $385-$391 (200 SMA / Bollinger upper band confluence). Avoid adding: Do not increase exposure at current levels ($370-$380). The 200 SMA has not been reclaimed and MACD momentum is decelerating.

RE-ENTRY TRIGGERS: 200 SMA reclaimed on closing basis with volume > 50-day average and RSI > 60 → add back toward benchmark. Or successful retest of $348-$353 with bullish reversal candle → starter position.

STOP/DOWNGRADE TRIGGERS: Daily close below $348 (50 SMA breakdown). Or Q3 earnings miss on margins (auto gross margin < 17%) or weak guidance.

TACTICAL BOUNCE TRADE: For accounts running tactical overlays, a bounce from $365-$370 toward $385 is supported by 92% Polymarket floor and compressed ATR. Setup: long at $365-$370, target $385, stop $353, position size = half-normal risk. This is a trade, not an investment thesis. Horizon: 1-3 weeks.

Q3 EARNINGS PLAY: Key catalyst ~2-3 weeks out. If margins compress further AND Q4 guidance is weak → cut to full Underweight, consider Sell. If margins hold AND forward EPS guidance exceeds $2.14 → shift to Hold. If Optimus or Robotaxi material commercial milestone announced → shift to Overweight.

HEDGING: At 1.92 beta, TSLA carries significant market beta. For accounts with concentrated TSLA exposure, consider buying 3-6 month $300-$320 puts as portfolio hedge. The 6% Polymarket tail and bear's $300-$330 base case provide rationale; cost should be modest given range-bound implied vol.

TIME HORIZON: Underweight rating reflects 3-6 month view. Tactical traders may run the bounce trade. Long-term investors should size to underweight and wait for either confirmed trend reversal (200 SMA reclaim) or structural reset (margin re-expansion) before increasing exposure.

The investment plan explicitly recommends Underweight on TSLA with clear instruction to trim 30-50% of position if at benchmark weight, reducing exposure to 50-70% of benchmark. Current price sits in the $370-$380 "avoid adding" zone identified by the plan. The structural bear case decisively outweighs the tactical bull case: 175x forward P/E requires flawless execution on Optimus/Robotaxi/FSD, operating margin has compressed to 1.41% with revenue +25.6% YoY but net income -5%, and a declining 200 SMA at $391 sits as overhead resistance. While the Polymarket 92% $365 floor and compressed ATR support a near-term bounce, the plan's higher-conviction structural thesis calls for trimming into any strength toward the $385-$391 confluence resistance zone (200 SMA / Bollinger upper band) rather than holding or adding at current levels.

Stop loss: $353.00

Sizing: Reduce TSLA exposure to 50-70% of benchmark weight. If currently at benchmark weight, trim 30-50% of the position. Preferred execution: scale sells into the $385-$391 trim zone (200 SMA / Bollinger upper band confluence) rather than chasing a lower print at spot.